Home Applications 011665 Application 011665
Type NDA
Sponsor BAUSCH Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 MESTINON PYRIDOSTIGMINE BROMIDE TABLET, EXTENDED RELEASE;ORAL 180MG Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N011665-001 MESTINON PYRIDOSTIGMINE BROMIDE 180MG TABLET, EXTENDED RELEASE / ORAL AB RLD, Approved before 1982
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N011665-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 N011665-001 MESTINON 180MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS, Approved before 1982 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N011665-001 MESTINON 180MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS, Approved before 1982 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N011665-001 MESTINON 180MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS, Approved before 1982 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N011665-001 MESTINON 180MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS, Approved before 1982 a50c72e98297…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 44 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 11 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0187-3013 Mestinon pyridostigmine bromide Bausch Health Americas, Inc. NDA Current 0187-3013 Mestinon pyridostigmine bromide Bausch Health US, LLC NDA Current 0187-3013 Mestinon pyridostigmine bromide Bausch Health US, LLC NDA Current 0187-3013 Mestinon pyridostigmine bromide Bausch Health US, LLC NDA Current 0187-3013 Mestinon pyridostigmine bromide Valeant Pharmaceuticals North America LLC NDA Current 0187-3013 Mestinon pyridostigmine bromide Bausch Health US, LLC NDA Current 0187-3013 Mestinon pyridostigmine bromide Bausch Health Americas, Inc. NDA Current 0187-3013 Mestinon pyridostigmine bromide Bausch Health US, LLC NDA Current 68682-301 pyridostigmine bromide pyridostigmine bromide Oceanside Pharmaceuticals NDA AUTHORIZED GENERIC Current 68682-301 pyridostigmine bromide pyridostigmine bromide Oceanside Pharmaceuticals NDA AUTHORIZED GENERIC Current 68682-301 pyridostigmine bromide pyridostigmine bromide Oceanside Pharmaceuticals NDA AUTHORIZED GENERIC Current
Documents# Document, Submission type, Date table Document Submission type Date 10771 SUPPL 2005-06-21